title: Neoadjuvant proton beam irradiation followed by transscleral resection of uveal melanoma in 106 cases.
abstract: OBJECTIVE
  To describe results after neoadjuvant proton beam irradiation followed by transscleral resection of large uveal melanoma.
  
  
  METHODS
  Retrospective interventional case series, including 106 consecutive patients. Local tumour control, enucleation and metastasis development were assessed with survival curves. Predictors of local recurrence and metastasis were investigated with log-rank testing.
  
  
  RESULTS
  Mean follow-up was 3.2 years. Local recurrence occurred in five cases with an estimated risk of 4.2% and 10.4% at 3 and 5 years after treatment, respectively. Enucleation was performed in 10 cases with an estimated risk of 9.2% and 18.4% at 3 and 5 years, respectively. Significant risk factors for local recurrence were not evident. Metastasis was estimated to occur in 28.4% at 3 years and 40.3% at 5 years, correlating with patient's age only (p=0.01). Seventy four patients (69.8%) underwent vitreoretinal surgery for complications after tumour resection. Median visual acuity (VA) was 20/50 at diagnosis and 20/400 in the third year after treatment. VA preservation of 20/200 or better was achieved in 33 patients (31.1%).
  
  
  CONCLUSIONS
  Neoadjuvant proton beam irradiation may help to prevent local recurrence after transscleral resection. Additional vitreoretinal surgery was frequently needed in the presented series. The majority of patients avoided enucleation and functional blindness.
authors.affiliation: Department of Ophthalmology, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany Department of Ophthalmology, DRK Kliniken Westend, Berlin, Germany.
authors.forename: Gregor D
authors.initials: GD
authors.lastname: Willerding
authors.affiliation: Department of Ophthalmology, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany Berlinprotonen at the Helmholtz-Zentrum Berlin, Lise-Meitner-Campus, Berlin, Germany.
authors.forename: Dino
authors.initials: D
authors.lastname: Cordini
authors.affiliation: Department of Radiotherapy and Radiation Oncology, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany Department of Radiotherapy, HELIOS Klinikum Emil von Behring, Berlin, Germany.
authors.forename: Lutz
authors.initials: L
authors.lastname: Moser
authors.affiliation: Department of Ophthalmology, Städtisches Klinikum, Dessau, Germany.
authors.forename: Lothar
authors.initials: L
authors.lastname: Krause
authors.affiliation: Department of Ophthalmology, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany Augenärzte Kurfürstendamm 102, Berlin, Germany.
authors.forename: Michael H
authors.initials: MH
authors.lastname: Foerster
authors.affiliation: Department of Ophthalmology, Medical University Innsbruck, Innsbruck, Austria.
authors.forename: Nikolaos E
authors.initials: NE
authors.lastname: Bechrakis
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015353:Eye Enucleation; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D013508:Ophthalmologic Surgical Procedures; D061766:Proton Therapy; D012189:Retrospective Studies; D012590:Sclera / Q000601:surgery*; D014604:Uveal Neoplasms / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D014792:Visual Acuity / Q000502:physiology; D000098943:Uveal Melanoma
keywords: Choroid; Ciliary body; Retina; Treatment Surgery